AllSight
Companies · LYB · Industrial Organic Chemicals · Earnings · Jul 31, 2026

Underlying earnings beat expectations as supply constraints lifted margins

Beatnew
Adjusted EPS $4.30 vs approximately $3.5 consensus
LyondellBasell Industries N.V. (LYB) — what happened, in plain English, and what it means versus what the market expected.

The quarter beat the market's earnings bar. Adjusted EPS was $4.30 versus published consensus around $3.5, while revenue of $9.177 billion was slightly below the approximately $9.25 billion expectation.

MetricQ2 2026Q1 2026Q2 2025Market comparison
Revenue$9.177B (Table 1 — Earnings Summary)$7.197B$7.658B~ $9.25B consensus
Adjusted EPS$4.30 (Table 3 — EPS reconciliation)$0.49$0.62~ $3.5 consensus
EBITDA excluding identified items$2.127B (Table 2 — EBITDA reconciliation)$615M$715M—
Operating cash flow$752M (Press release — Cash Flow)———

The earnings beat was operational, not just accounting-driven. Excluding identified items, EBITDA jumped to $2.127 billion from $615 million in the first quarter, led by a $940 million improvement in O&P-Americas and a $162 million increase in Intermediates & Derivatives (Segment results — O&P-Americas; Segment results — I&D). The main driver was wider polymer and chemical margins as supply disruptions tightened markets.

The headline GAAP result is distorted by the European asset sale. LyondellBasell recorded a $734 million pre-tax loss on the divestiture, plus $74 million of asset write-downs, leaving reported EPS at only $1.71 versus $4.30 excluding identified items (Table 2 — Net income reconciliation; Table 3 — EPS reconciliation). The divestiture itself was already announced and completed in May, so its completion is confirmation rather than a fresh surprise.

The quality of the upside is cyclical and partly exposed to reversal. North American O&P operated at roughly 90% utilization, while management expects third-quarter rates of 85% in North American O&P, 70% in European O&P and 85% in Intermediates & Derivatives (Press release — Operating outlook). Management also flagged continued uncertainty over when conflict-related supply returns, making the unusually strong spreads less clearly structural.

The net read is a genuine beat, with balance-sheet execution still important. Liquidity was $7.090 billion, operating cash flow was $752 million, and the company remains on target for $500 million of incremental cash from its improvement plan by year-end (Table 4 — Liquidity; Press release — Cash Flow and Cash Improvement Plan). The scheduled debt maturity repayment in September is the next concrete test of that deleveraging plan.

Read the original 8-K on SEC EDGAR ↗
All LYB filings, decoded →
Related companies in Industrial Organic Chemicals
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact